WASHINGTON — At a congressional hearing on genetic engineering framed in part as a learning session, lawmakers queried experts from academia and industry on the technology’s power to change human health and and how the government could best support the scientists working on it.

“Today’s hearing is truly a hearing,” Republican Lamar Alexander, chairman of the Senate Health, Education, Labor and Pensions committee, said at the start. “I intend to do more listening than talking.”

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy